In fiscal 2012, which ended Dec 31, 2012, Innovaro, Inc. used $1.7 million of cash from operations, up 40.8% from the year before. It spent $1,279 on capital expenditures. Free cash flow was negative, at -$1.7 million.
USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.
| Line |
FY 2013
Sep 30, 2013
|
FY 2012
Dec 31, 2012
|
FY 2011
Dec 31, 2011
|
|---|---|---|---|
| Operating | |||
| Depreciation and amortization |
0
-55.9%
|
1
-11.3%
|
1
|
| Stock-based compensation |
0
-81.3%
|
0
-34.6%
|
0
|
| Operating cash flow |
-1
+38.2%
|
-2
+40.8%
|
-3
|
| Investing | |||
| Capital expenditures |
0
+364.1%
|
0
-96.7%
|
0
|
| Investing cash flow |
1
+37.6%
|
1
+423.7%
|
-0
|
| Financing | |||
| Debt repaid |
1
+21.4%
|
1
+17.7%
|
1
|
| Financing cash flow |
0
+145.5%
|
-0
+78.3%
|
-0
|
| Change in cash | |||
| Free cash flow |
-1
+35.5%
|
-2
+41.6%
|
-3
|
| Per share | |||
| Free cash flow per share |
—
|
-0.11
|
—
|
| Ratios | |||
| Free cash flow margin |
-244.41%
|
-316.08%
|
-659.27%
|
| Capital expenditures to revenue |
11.56%
|
0.24%
|
9.01%
|
| Stock-based compensation to revenue |
11.15%
|
36.15%
|
67.35%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.
Company profile
- Industry
- Blank Checks (SIC 6770)
- Listed as
- INNI (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Charlotte, NC
- SEC CIK
- 1098482
- Former names
- UTEK CORP (until Jul 12, 2010)
Other Blank Checks companies
- Drugs Made In America Acquisition II Corp. DMII
- EQV Ventures Acquisition Corp. II EVAC
- Bain Capital GSS Investment Corp. BCSS
- Cantor Equity Partners IV, Inc. CEPF
- Churchill Capital Corp XII CXII
- American Exceptionalism Acquisition Corp. A AEXA
- New America Acquisition I Corp. NWAX
- Ares Acquisition Corp III AAC
Source: SEC EDGAR filings. This is company-reported data, not investment advice.